Pharmacokinetics of ceftazidime in patients with renal insufficiency
- 1 February 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (2) , 201-204
- https://doi.org/10.1128/aac.25.2.201
Abstract
The pharmacokinetics of ceftazidime were studied in 14 adult volunteers with different degrees of renal function. The elimination of ceftazidime was totally dependent on renal excretion. The clearance of ceftazidime ranged from 7.5 to 145.1 ml/min and correlated with both renal ceftazidime clearance and creatinine clearance (ClCR). It is recommended that 0.5 to 2.0 g of ceftazidime be given in extended dosages, with intervals dependent on the renal function of the patient. Patients with a ClCR of greater than 50 ml/min should be given ceftazidime every 8 h, those with a ClCR of 30 to 50 ml/min should be given the drug every 12 h, those with a ClCR of 15 to 30 ml/min should be given the drug once a day, and individuals with a ClCR of less than 15 ml/min should be given the drug on a day, and individuals with a ClCR of less than 15 ml/min should be given the drug on a 36- to 48-h regimen.This publication has 4 references indexed in Scilit:
- Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and CeftazidimeAntimicrobial Agents and Chemotherapy, 1981
- Transferable multiple antibiotic resistance in Haemophilus influenzaeJournal of Antimicrobial Chemotherapy, 1981
- The tetracyclines: prospects at the beginning of the 1980sJournal of Antimicrobial Chemotherapy, 1981
- Resistance to -lactam antibiotics in Bacteroides speciesJournal of Antimicrobial Chemotherapy, 1981